AP NEWS
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.
PRESS RELEASE from provider: Business Wire
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.

2018-2019 Pharmaceuticals Research Review - Analysis on Cognition & Memory Enhancement Drugs; Circulating Tumor Cell (CTC) Diagnostics; Viral Vector Manufacturing; Checkpoint Inhibitors; and more - ResearchAndMarkets.com

February 25, 2019

DUBLIN--(BUSINESS WIRE)--Feb 25, 2019--The “2018 Pharmaceuticals Research Review” report has been added to ResearchAndMarkets.com’s offering.

The pharmaceutical sector is undergoing expansions driven by the unmet need in several disease areas. Launch of novel therapies, that included cell and gene therapy with an increase in access to medicines is also driving the growth of the pharmaceutical market.

The approval of second CAR T-cell therapy tisagenlecleucel (Kymriah) in 2018 signifies the dramatic progress in the field. Pharmaceutical sector witnessed uncertainties due to the US presidential elections, and weak economic growth in 2017 which have now settled down leading to steady growth in the sector.

Pharmaceutical industry is continuing the pursuit of drug discovery, and development for meeting the worldwide unmet need in the area of oncology, and orphan diseases with an unprecedented rigor. Pharma sector ratifies this trend with a rich cancer pipeline, availability of clinical and real-world data and an increase in associated investments.

Pharma industry would surge owing to mergers and acquisitions that bolster company’s portfolio, drive innovation, and unlocks synergies. The merger announcement of Bristol-Myers Squibb and Celgene would create a new biopharmaceutical leader with deep and broad pipeline to deliver high-value innovation medicines.

Topics Covered

Chapter 1 Foreword

  • Foreword

Chapter 2 Cognition and Memory Enhancement Drugs: Technologies and Global Markets

  • Introduction
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources and Methodology
  • Intended Audience
  • Geographic Breakdown
  • Analyst’s Credentials
  • Custom Research
  • Related Reports
  • Summary and Highlights
  • Market Definition
  • Ethics and Cognition and Memory-enhancing Drugs
  • Treatments Available for Dementia
  • Cholinesterase Inhibitors
  • Memantine
  • Nondrug Treatments for Dementia
  • Availability of Dementia Treatments
  • Side Effects of Cognition and Memory-enhancing Drugs
  • Benefits and Side Effects of Consuming Cognition Drugs
  • Technology Trends
  • Recent Studies Highlighting Potential of Cognition Drugs in Chess
  • Market Breakdown by Application
  • Alzheimer’s Disease
  • Patents Overview
  • Patent Analysis
  • Patents Filed in Asia-Pacific

Chapter 3 Circulating Tumor Cell (CTC) Diagnostics: Technologies and Global Markets

  • Introduction
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Intended Audience
  • Scope of the Study
  • Methodology
  • Information Sources
  • Geographic Breakdown
  • Analyst’s Credentials
  • Related Reports
  • Summary and Highlights
  • Cancer
  • Recent Advances in Technology
  • Invasive Power
  • Circulating Tumor Cells
  • Phenotypic Characteristics
  • CTC Clusters
  • CTC Detection
  • Circulating Tumor Cells - Potential Uses
  • Circulating Tumor Cell Market - A New Approach
  • Current Status of the Market
  • Patents Overview
  • Key Patents

Chapter 4 Global Viral Vector Manufacturing Markets and Technologies Through 2022

  • Introduction
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Methodology
  • Geographic Breakdown
  • Analyst’s Credentials
  • Related Research Reports
  • Summary and Highlights
  • Market and Technology Background
  • Market Potential
  • WHO
  • Market Segmentation
  • Segmentation by Type
  • Overview

Chapter 5 Checkpoint Inhibitors: Global Markets

  • Introduction
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst’s Credentials
  • Related Reports
  • Summary and Highlights
  • Immuno-Oncology
  • Costimulatory Immune Checkpoint Targets
  • Inhibitory Immune Checkpoint Targets
  • Immunometabolic Modulatory Targets
  • Unmet Medical Needs
  • New Biomarkers to Stratify Patients
  • Relapse/Refractory Patients
  • PD-1/PD-L1 Agents Introduction
  • Market Forecasts

Chapter 6 Lysosomal Disease Treatments: Technologies and Global Markets

  • Introduction
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst’s Credentials
  • Related Reports
  • Summary and Highlights
  • Definition
  • Lysosomes
  • Lysosomal Storage Diseases
  • Most Common LSDs
  • Market Breakdown by Region
  • North America

Chapter 7 High-Throughput Screening: Technologies and Global Markets

  • Introduction
  • Study Goals and Objectives
  • Intended Audience
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst’s Credentials
  • Related Reports
  • Summary and Highlights
  • Evolution of High-Throughput Screening
  • Miniaturization of Assays for High-Throughput Screening
  • Optimization of High-Throughput Screening
  • Conclusion
  • Artificial Intelligence and Automated Devices in HTS
  • Mass Spectrometry (MS)
  • Imaging Mass Spectrometry
  • MALDI Mass Spectrometry
  • Secondary Ion Mass Spectrometer
  • Mass Spectrometry Instruments
  • Patent Analysis

Chapter 8 Neuroprotective Agents: Therapeutic Applications and Global Markets

  • Introduction
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst’s Credentials
  • Related Reports
  • Summary and Highlights
  • Neuroprotection
  • Why Are Neuroprotective Therapies Needed?
  • Neuroprotective Strategies
  • Market Breakdown by Therapeutic Indication
  • Neuroprotective Agents for Cerebrovascular Disease

For more information about this report visit https://www.researchandmarkets.com/research/9k93v8/20182019?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190225005933/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 02/25/2019 02:32 PM/DISC: 02/25/2019 02:32 PM

http://www.businesswire.com/news/home/20190225005933/en